🇺🇸 FDA
Patent

US 9297009

UNA oligomers targeting micro-RNA for therapeutics

granted A61PA61P35/00

Quick answer

US patent 9297009 (UNA oligomers targeting micro-RNA for therapeutics) held by ARCTURUS THERAPEUTICS, INC. expires Mon Mar 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ARCTURUS THERAPEUTICS, INC.
Grant date
Tue Mar 29 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61P, A61P35/00